Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

(ANTX) logo

About (ANTX) Stock (NYSE:ANTX)

Advanced Chart

Key Stats

Today's Range
$1.22
$1.26
50-Day Range
N/A
52-Week Range
$0.87
$2.74
Volume
83,337 shs
Average Volume
360,333 shs
Market Capitalization
$31.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
Consensus Rating
Hold

Company Overview

Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

ANTX Stock News Headlines

Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%.
AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI
Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)
See More Headlines

ANTX Stock Analysis - Frequently Asked Questions

(ANTX) (NYSE:ANTX) posted its earnings results on Tuesday, August, 13th. The company reported ($0.48) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.59) by $0.11.

(ANTX) (ANTX) raised $69 million in an initial public offering on Friday, March 25th 2022. The company issued 4,600,000 shares at $14.00-$16.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Broadcom (AVGO), NVIDIA (NVDA), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/13/2024
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:ANTX
Previous Symbol
NASDAQ:ANTX
CIK
1156093
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$2.00
Low Price Target
$1.00
Potential Upside/Downside
+40.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-57.62%
Return on Assets
-52.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.75
Quick Ratio
9.75

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
0.25

Miscellaneous

Outstanding Shares
29,880,000
Free Float
23,667,000
Market Cap
$31.82 million
Optionable
Not Optionable
Beta
0.15
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:ANTX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners